- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06369779
Clinical Evaluation of a New Flowable and a New Sculptable Universal Bulk-fill Composite for Direct Restorative Treatment
April 12, 2024 updated by: Ivoclar Vivadent AG
Clinical Evaluation of Class I and II Cavities Restored With the Combination of a New Flowable and a New Sculptable Universal Bulk-fill Composite: A Prospective Single Arm Study
The overall objective of this clinical investigation is to evaluate the clinical safety and performance of the new flowable composite TM Flow and the new sculptable composite TM Fill for restoration of class I and class II cavities.
The fillings are assessed according to selected FDI criteria at baseline (7-10 days after placement of filling) and after 1, 6, 12, 24, 36 and 60 months.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
65
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Informed Consent signed by the subject
- Age: 18-65 years
- Indication Class I or II direct restorations in premolars or molars (Replacement of insufficient fillings due to secondary caries, fractures, insufficient marginal adaptation, loss of filling or primary caries)
- Cavity width must be at least half of the cusp tip distance
- Vital teeth, regular sensitivity
- Sufficient language skills
- No active periodontits
- Preoperative VAS values < 3 regarding tooth sensitivity and biting
Exclusion Criteria:
- Sufficient isolation of the cavity not possible
- Not completed hygiene phase or poor oral hygiene
- Missing antagonist, non-occlusion
- Missing tooth adjacent to the tooth to be treated
- Restorations replacing more than 1 cusp
- Caries profunda or very deep cavity
- Patients with a proven allergy to ingredients of the used materials (methacrylates) or local anesthetics (Articain, sulfite)
- Patients with severe systemic diseases
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Test group (TM Fill and TM Flow)
TM Fill an TM Flow are used for restoration of class I and class II cavities
|
The newly developed resin composites TM Flow and TM Fill will be used for the restoration of class I and II cavities (3 seconds light-curing mode, 3000 mW/cm2).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative hypersensitivity
Time Frame: 1 month
|
will be assessed acooriding to FDI criteria
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluation of functional (e.g. fracture of the material and retention), biological (e.g. caries at restoration margins) and aesthetic (e.g. color match) properties of the restorations
Time Frame: 5 years
|
will be assessed acooriding to FDI criteria
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2024
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2030
Study Registration Dates
First Submitted
April 12, 2024
First Submitted That Met QC Criteria
April 12, 2024
First Posted (Actual)
April 17, 2024
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 12, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- OTCS 36406866
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Class I or II Cavities in Premolars or Molars
-
Aga Khan UniversityCompletedClass II Caries in PremolarsPakistan
-
Cairo UniversityUnknownClass I Cavities in High Caries RiskEgypt
-
InnoRa GmbHTerminatedLesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/IIGermany
-
Xiyuan Hospital of China Academy of Chinese Medical...UnknownRehabilitation With CHF; NYHA Class I or IIChina
-
Medtronic Cardiac Rhythm and Heart FailureCompletedClass I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National GuidelinesUnited States, Netherlands, Japan, Serbia, Spain, Greece, Canada, India, Denmark, Czechia, South Africa, Malaysia, Austria, United Kingdom, Hungary, China, Australia, France, Italy
-
Al-Azhar UniversityCompleted
-
Damascus UniversityCompletedClass II MalocclusionSyrian Arab Republic
-
Creative Testing SolutionsCompletedHuman T-Lymphotrophic Virus Type I and/or Type IIUnited States
-
Cairo UniversityUnknownClass III Malocclusion | Class II Malocclusion
-
Dr. Fareena GhaffarCompletedClass II Division 1 Malocclusion | Mandibular RetrognathismPakistan
Clinical Trials on TM Fill and TM Flow
-
University Hospital TuebingenTerminatedApnea of Prematurity | Continuous Positive Airway Pressure | CPAP
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Atrium...CompletedVentral Hernia | AdhesionsUnited States
-
NephroSantNot yet recruitingKidney Transplant Failure and Rejection
-
Tufts UniversityBioElectronics CorporationTerminatedPostoperative Edema and PainUnited States
-
Boston UniversityNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruitingHIV Infections
-
BioTech Tools S.A.Completed
-
Zimmer BiometActive, not recruitingOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Revision Total Shoulder Arthroplasty | Ununited Humeral Head Fracture | Irreducible 3-and 4-part Proximal Humeral Fractures | Gross Rotator Cuff DeficiencyUnited States, United Kingdom
-
University Hospital Inselspital, BerneEdwards LifesciencesCompletedVasodilation | Vasoconstriction | Hemodynamics | Cardiac Output, Low | Cardiac Output, HighSwitzerland
-
University of Southern DenmarkOdense University Hospital; University of Ghana; Odense Patient Data Explorative... and other collaboratorsCompletedAcquired Immunodeficiency Syndrome | Tuberculosis, Pulmonary | Human Immunodeficiency Virus (HIV) | Extrapulmonary TuberculosisGhana
-
BioStream Technologies, LLCCompletedAutism Spectrum DisorderUnited States